Impact BioMedical Inc.
IBO
$0.4324
$0.00741.74%
AMEX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -17.80% | 114.63% | |||
| Depreciation & Amortization | -0.71% | 0.72% | |||
| Other Operating Expenses | 151.11% | 275.00% | |||
| Total Operating Expenses | -22.36% | 80.03% | |||
| Operating Income | 22.36% | -80.03% | |||
| Income Before Tax | -739.00% | 579.75% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -739.78% | 579.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 316.67% | 220.00% | |||
| Net Income | -738.29% | 577.73% | |||
| EBIT | 22.36% | -80.03% | |||
| EBITDA | 22.40% | -80.00% | |||
| EPS Basic | -737.95% | 515.30% | |||
| Normalized Basic EPS | -140.06% | 513.80% | |||
| EPS Diluted | -4,025.50% | 166.67% | |||
| Normalized Diluted EPS | -350.68% | 166.13% | |||
| Average Basic Shares Outstanding | 0.05% | 15.07% | |||
| Average Diluted Shares Outstanding | -84.01% | 620.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||